Coronary revascularization trends in the united states, 2001-2008

JAMA

Volumn 305, Issue 17, 2011, Pages 1769-1776

  Epstein, Andrew J ^a,b,c   Polsky, Daniel ^b,c   Yang, Feifei ^b   Yang, Lin ^b   Groeneveld, Peter W ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOPLASTY; ARTICLE; BARE METAL STENT; BILLING AND CLAIMS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RURAL AREA; TREND STUDY; UNITED STATES; URBAN AREA;

EID: 79955624770     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.551     Document Type: Article

References (29)

1. DeFrances CJ, Lucas CA, Vuie VC, Golosinskiy A. 2006 National Hospital Discharge Survey. Hyattsville, MD: National Center for Health Statistics; 2008.
2. Centers for Medicare & Medicaid Services. Inpatient hospital payment information for value-driven health care. http://www.cms.gov/HealthCareConInit /02-Hospital.asp. Accessed February 24, 2010.
3. Roe MT, Chen AY, Cannon CP, et al. Temporal changes in the use of drug-eluting stents for patients with non-ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008. Circ Cardiovasc Qual Outcomes. 2009;2(5):414-420.
4. Hernandez AF, Li S, Dokholyan RS, O'Brien SM, Ferguson TB, Peterson ED. Variation in perioperative vasoactive therapy in cardiovascular surgical care: data from the Society of Thoracic Surgeons. Am Heart J. 2009;158(1):47-52.
5. Li Z, Yeo KK, Parker JP, Mahendra G, Young JN, Amsterdam EA. Off-pump coronary artery bypass graft surgery in California, 2003 to 2005. Am Heart J. 2008; 156(6):1095-1102.
6. Moses JW, Leon MB, Popma JJ, et al. Sirolimus- eluting stents versus standard stents in patients with stenosis in a native coronary artery.NEnglJMed. 2003; 349(14):1315-1323. (Pubitemid 37186209)
7. Stone GW, Ellis SG, Cox DA, et al. A polymerbased, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3): 221-231. (Pubitemid 38067635)
8. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-1516. (Pubitemid 46588415)
9. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronaryartery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-972.
10. Eagle KA, Guyton RA, Davidoff R, et al. ACC/ AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol. 2004; 44(5):e213-e310.
11. Eagle KA, Guyton RA, Davidoff R, et al. ACC/ AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol. 1999;34(4):1262-1347.
12. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/ SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J AmColl Cardiol. 2009; 53(6):530-553.
13. Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/ AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines): executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 2001;37(8):2215-2239.
14. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006;47(1):216-235.
15. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project: Introduction to the Nationwide Inpatient Sample (NIS) 2008. http: //www.hcup-us.ahrq.gov/db/nation/nis /NIS-2008-INTRODUCTION.pdf. Accessed March 8, 2010.
16. US Census Bureau. Annual estimates of the resident population by sex and selected age groups for the United States: April 1, 2000 to July 1, 2009 (NC-EST2009-02). http://www.census.gov/popest /national/asrh/NC-EST2009-sa.html. Accessed March 2, 2011.
17. Cohen MM, Wreford M, Barnes M, Voight P. Reengineering surgical services in a community teaching hospital. Cost Qual Q J. 1997;3(2):48-57.
18. Groeneveld PW, Matta MA, Greenhut AP, Yang F. Drug-eluting compared with bare-metal coronary stents among elderly patients. JAmColl Cardiol. 2008; 51(21):2017-2024. (Pubitemid 351680528)
19. Gogo PB Jr, Dauerman HL, Mulgund J, et al. Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative). Am J Cardiol. 2007;99(9):1222-1226. (Pubitemid 46661929)
20. Dunlay SM, Rihal CS, Sundt TM, Gerber Y, Roger VL. Current trends in coronary revascularization. Curr Treat Options Cardiovasc Med. 2009;11(1):61-70.
21. Frutkin AD, Lindsey JB, Mehta SK, et al. Drugeluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2009;2(7):614-621.
22. Rathore SS, Epstein AJ, Volpp KG, Krumholz HM. Hospital coronary artery bypass graft surgery volume and patient mortality, 1998-2000. Ann Surg. 2004;239(1):110-117.
23. Vaughan-Sarrazin MS, Hannan EL, Gormley CJ, Rosenthal GE.Mortality in Medicare beneficiaries following coronary artery bypass graft surgery in states with and without certificate of need regulation. JAMA. 2002;288(15):1859-1866. (Pubitemid 35168141)
24. Krone RJ, Rao SV, Dai D, et al. Acceptance, panic, and partial recovery the pattern of usage of drugeluting stents after introduction in the U.S. (a report from the American College of Cardiology/National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2010;3(9):902-910.
25. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimuseluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562):667-678. (Pubitemid 46281313)
26. Shuchman M. Trading restenosis for thrombosis? new questions about drug-eluting stents. N Engl J Med. 2006;355(19):1949-1952. (Pubitemid 44708012)
27. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297 (2):159-168. (Pubitemid 46089732)
28. Anderson HV, Shaw RE, Brindis RG, et al. A contemporary overview of percutaneous coronary interventions. J Am Coll Cardiol. 2002;39(7):1096-1103.
29. Harrison JP, Coppola MN, Wakefield M. Efficiency of federal hospitals in the United States.JMed Syst. 2004;28(5):411-422. (Pubitemid 39663110)